Inhibition of autophagy potentiates cytotoxicity of CX-5461 treatment in chemoresistant epithelial ovarian cancer

被引：1
|
作者：
Cornelison, Robert
Llaneza, Danielle C.
Petrova, Yulia
Dobbin, Zachary C.
Schneider, David A.
Landen, Charles N.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-3211
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3211
引用
收藏
页数：2
相关论文
共 50 条
  • [1] CX-5461 Treatment Leads to Cytosolic DNA-Mediated STING Activation in Ovarian Cancer
    Cornelison, Robert
    Biswas, Kuntal
    Llaneza, Danielle C.
    Harris, Alexandra R.
    Sosale, Nisha G.
    Lazzara, Matthew J.
    Landen, Charles N.
    CANCERS, 2021, 13 (20)
  • [2] Targeting RNA-polymerase I using CX-5461 as a mechanism for treating chemotherapy resistant epithelial ovarian cancer
    Cornelison, Robert
    Dobbin, Zachary C.
    Katie, Ashwini A.
    Jeong, Dae Hoon
    Petrova, Yulia
    Llaneza, Danielle C.
    Steg, Adam D.
    Zhang, Yinfeng
    Schneider, David A.
    Landen, Charles N.
    CANCER RESEARCH, 2016, 76
  • [3] Inhibition of ATR Potentiates Acute Myeloid Leukemia Cells to the RNA Pol I Transcription Inhibitor CX-5461
    Shatara, Margaret
    Wang, Tingting
    Li, Xinyu
    Edwards, Holly
    Taub, Jeffrey W.
    Lin, Hai
    Ge, Yubin
    BLOOD, 2018, 132
  • [4] The primary mechanism of cytotoxicity of the chemotherapeutic agent CX-5461 is topoisomerase II poisoning
    Bruno, Peter M.
    Lu, Mengrou
    Dennis, Kady A.
    Inam, Haider
    Moore, Connor J.
    Sheehe, John
    Elledge, Stephen J.
    Hemann, Michael T.
    Pritchard, Justin R.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (08) : 4053 - 4060
  • [5] CX-5461 can destabilize replication forks in PARP inhibitor-resistant models of ovarian cancer
    Xuan, Jiachen
    Pearson, Richard B.
    Sanij, Elaine
    MOLECULAR & CELLULAR ONCOLOGY, 2020, 7 (06)
  • [6] Inhibition of Nucleotide Excision Repair by Anti-Cancer, G-Quadruplex DNABinding Drug CX-5461
    Berroyer, Alexandra
    Pecen, Turner
    Kim, Hyun Suk
    Kim, Mihyun
    Scharer, Orlando D.
    Nagel, Zachary D.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2023, 64 : 87 - 88
  • [7] The G-quadruplex ligand CX-5461: an innovative candidate for disease treatment
    Hong-Xia Li
    Yi-Meng He
    Jing Fei
    Man Guo
    Chen Zeng
    Pi-Jun Yan
    Yong Xu
    Gang Qin
    Fang-Yuan Teng
    Journal of Translational Medicine, 23 (1)
  • [8] CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer
    Elaine Sanij
    Katherine M. Hannan
    Jiachen Xuan
    Shunfei Yan
    Jessica E. Ahern
    Anna S. Trigos
    Natalie Brajanovski
    Jinbae Son
    Keefe T. Chan
    Olga Kondrashova
    Elizabeth Lieschke
    Matthew J. Wakefield
    Daniel Frank
    Sarah Ellis
    Carleen Cullinane
    Jian Kang
    Gretchen Poortinga
    Purba Nag
    Andrew J. Deans
    Kum Kum Khanna
    Linda Mileshkin
    Grant A. McArthur
    John Soong
    Els M. J. J. Berns
    Ross D. Hannan
    Clare L. Scott
    Karen E. Sheppard
    Richard B. Pearson
    Nature Communications, 11
  • [9] CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer
    Sanij, Elaine
    Hannan, Katherine M.
    Xuan, Jiachen
    Yan, Shunfei
    Ahern, Jessica E.
    Trigos, Anna S.
    Brajanovski, Natalie
    Son, Jinbae
    Chan, Keefe T.
    Kondrashova, Olga
    Lieschke, Elizabeth
    Wakefield, Matthew J.
    Frank, Daniel
    Ellis, Sarah
    Cullinane, Carleen
    Kang, Jian
    Poortinga, Gretchen
    Nag, Purba
    Deans, Andrew J.
    Khanna, Kum Kum
    Mileshkin, Linda
    McArthur, Grant A.
    Soong, John
    Berns, Els M. J. J.
    Hannan, Ross D.
    Scott, Clare L.
    Sheppard, Karen E.
    Pearson, Richard B.
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [10] CX-5461 Sensitizes DNA Damage Repair-proficient Castrate-resistant Prostate Cancer to PARP Inhibition
    Lawrence, Mitchell G.
    Porter, Laura H.
    Choo, Nicholas
    Pook, David
    Grummet, Jeremy P.
    Pezaro, Carmel J.
    Sandhu, Shahneen
    Ramm, Susanne
    Luu, Jennii
    Bakshi, Andrew
    Goode, David L.
    Sanij, Elaine
    Pearson, Richard B.
    Hannan, Ross D.
    Simpson, Kaylene J.
    Taylor, Renea A.
    Risbridger, Gail P.
    Furic, Luc
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (11) : 2140 - 2150
12345